DrugDashboards

Market view

tiotropium bromide and olodaterol

3 marketed package NDCs · 1 active manufacturer

Most dispensed: MONOHYDRATE 3.124 ug; HYDROCHLORIDE 2.736 ug · Spray, Metered · #1 cartridge/carton / 60 spray, metered in 1 cartridge

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $115.79 per gram over the past year.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$50.00$100.00$150.00Oct 2015Sep 202601companies actively selling

Latest · Sep 2026 — typical price $115.79 · middle half $115.79$115.79 · full range $115.79$115.79 · 1 products · 1 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per gramSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for tiotropium bromide and olodaterol, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Stiolto RespimatSep 2, 2026
    Mfr exited
    Boehringer Ingelheim Pharmaceuticals, Inc. · tiotropium bromide and olodaterol
  • Stiolto RespimatAug 26, 2026
    Mfr entered
    Boehringer Ingelheim Pharmaceuticals, Inc. · tiotropium bromide and olodaterol
  • Stiolto RespimatAug 19, 2026
    Price down
    NADAC $115.82046 → $115.79129 per unit (-0.03%)
  • Stiolto RespimatJul 29, 2026
    Mfr exited
    Boehringer Ingelheim Pharmaceuticals, Inc. · tiotropium bromide and olodaterol
  • Stiolto RespimatJul 22, 2026
    Price up
    NADAC $115.81415 → $115.82046 per unit (+0.01%)
  • Stiolto RespimatJul 22, 2026
    Mfr entered
    Boehringer Ingelheim Pharmaceuticals, Inc. · tiotropium bromide and olodaterol

Same drug class

Other molecules FDA puts in beta2-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Tiotropium bromide and olodaterol in shortage right now?
No. FDA does not currently list Tiotropium bromide and olodaterol in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Tiotropium bromide and olodaterol?
1 company has marketed Tiotropium bromide and olodaterol in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
What does Tiotropium bromide and olodaterol cost?
The typical pharmacy pays about $115.79 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.